Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) just unveiled an announcement.
Respighi BidCo S.p.A. has launched a voluntary full public tender offer for all ordinary shares of Recordati S.p.A., with the Italian securities regulator CONSOB approving the official offer document. The document will be made available via the company, intermediaries and the Global Information Agent, providing shareholders with detailed terms before the offer period opens.
The acceptance period for Recordati shareholders is scheduled from 31 August 2026 to 15 October 2026, with a consideration of €51.29 per share to be paid on 23 October 2026 if the offer completes. Subject to conditions being met, the offer terms may be reopened for an additional five trading days in late October, with a second payment date in November, giving investors a structured timetable to evaluate and respond to the bid.
The most recent analyst rating on (IT:REC) stock is a Buy
with a EUR57.50 price target.
To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock,
see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati S.p.A. is an Italy-based pharmaceutical company focused on the research, development and commercialization of prescription medicines. It operates in international markets with a portfolio that includes specialty and rare disease treatments, serving both primary care and specialist segments.
The company targets growth through branded pharmaceuticals and maintains a significant presence in Europe and other global regions. Its shares are listed on the Italian market, making it a prominent player in the country’s healthcare and life sciences sector.
Average Trading Volume: 447,248
Technical Sentiment Signal: Strong Buy
Current Market Cap: €10.62B
For detailed information about REC stock, go to TipRanks’ Stock Analysis page.